Julia Carnevale is an Oncology physician affiliated with Gladstone Institutes. OpenAlex indexes 70 publications with 2,941 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
533 Parnassus Ave
San Francisco, CA 941432208
Telephone
415-353-2739Registry record last updated 10 Dec 2018.
Medicare prescribing footprint (2021)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
53.1%Phenothiazine53.1%Prochlorperazine Maleate100%Part D<11 patientsMetabolism & gastrointestinal
46.9%Serotonin-3 Receptor Antagonist46.9%Ondansetron Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
4 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- Genome-Wide In Vivo CRISPR Screens in Human T Cells Identify GPCR Pathway Targets to Enhance CAR-T Therapies for Solid Tumors
University of California, San Francisco
FY2026$680,597R01CA309039 - Genetic Engineering of Myeloid Cells to Treat Cancer
University of California, San Francisco
FY2025$1,476,000DP2CA311215 - Decoding the Cullin-5 complex to engineer therapeutic T cells with durable effector function
University of California, San Francisco
FY2025$680,598R01CA296797
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells
bioRxiv (Cold Spring Harbor Laboratory)
2025 - In vivo genome-wide CRISPR screens in human T cells to enhance T cell therapy for solid tumors
bioRxiv (Cold Spring Harbor Laboratory)
2025 - Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity
Nature Communications
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Lennart Mucke, MD
Gladstone Institutes
Hayes Gladstone, MD
Gladstone Institutes
Rangarajan Nadadur, MD
Gladstone Institutes
Alan Baik, MD
Gladstone Institutes
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”